长非编码RNA治疗癌症的进展:向,交付和临床影响
Muhammad Ammad1, Zeeshan Javed2, Haleema Sadia3
1Department of Biotechnology, University of Karachi, Karachi, Pakistan.
Medical oncology (Northwood, London, England)
|October 20, 2024
概括
长非编码RNAs (lncRNAs) 是细胞过程的关键调节者,具有预防癌症的潜力. 本综述探讨了lncRNA生物学,输送系统和针对性治疗的临床试验.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 生物技术是生物技术.
背景情况:
- 长非编码RNAs (lncRNAs) 调节重要的细胞过程,如发育和分化.
- 尽管有潜在的治疗应用,但它们在预防癌症中的作用尚未得到充分探索.
- lncRNAs提供独特的二次结构和序列动机作为新疗法的目标.
研究的目的:
- 审查当前的lncRNA生物学和作用机制.
- 探索纳米配方策略,以提供 lncRNA.
- 检查涉及 lncRNA 传递系统用于疾病治疗的临床试验.
主要方法:
- 关于 lncRNA 研究的文献评论.
- 对lncRNA向策略 (小分子,反意义寡核酸) 的分析.
- 检查药物输送系统和核酸修饰方面的进展.
主要成果:
- lncRNAs与各种人类病理有关.
- 针对 lncRNAs 显示出疾病预防和治疗的前景.
- 在为lncRNA疗法开发特定和有效的输送工具方面,仍然存在挑战.
- 最近的进展提高了药物的稳定性,降低了免疫性,但需要进一步的进展.
结论:
- 基于lncRNA的疗法具有治疗癌症等复杂疾病的巨大潜力.
- 对优化交付系统的进一步研究对于临床翻译至关重要.
- 继续探索 lncRNA 生物学和治疗策略是有必要的.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
464
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
